Literature DB >> 22820286

How many neutrophils are enough (redux, redux)?

Samuel C Silverstein, Raul Rabadan.   

Abstract

Many chemotherapeutic regimens produce neutropenia, which predisposes to microbial infection. However, not all neutropenic individuals develop infections, so the ability to predict this outcome would be a powerful clinical tool. In this issue of the JCI, Malka et al. describe a dynamic system model of neutrophil bactericidal activity that confirms and extends the concept of critical neutrophil concentration. The authors demonstrate that when the neutrophil concentration approaches the critical concentration, bacterial populations in contact with them exhibit bistability. Their experimental findings raise the intriguing possibility of greater variability in bactericidal activity of neutrophils from healthy adults than heretofore recognized; their model predicts that this could have life-and-death consequences.

Entities:  

Year:  2012        PMID: 22820286      PMCID: PMC3533502          DOI: 10.1172/JCI63939

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; I Dubbeldeman-Rempt; R van Furth
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

2.  How many "polys" are enough?

Authors:  W H Crosby
Journal:  Arch Intern Med       Date:  1969-06

3.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

4.  Leukocytes in the peripheral blood of the developing opossum.

Authors:  J H Cutts; W J Krause
Journal:  J Anat       Date:  1980-01       Impact factor: 2.610

5.  The bacterial peptide N-formyl-Met-Leu-Phe inhibits killing of Staphylococcus epidermidis by human neutrophils in fibrin gels.

Authors:  Yongmei Li; John D Loike; Julia A Ember; P Patrick Cleary; Emily Lu; Sadna Budhu; Long Cao; Samuel C Silverstein
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 6.  Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Authors:  Jeffrey Crawford; David C Dale; Gary H Lyman
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

7.  A critical concentration of neutrophils is required for effective bacterial killing in suspension.

Authors:  Yongmei Li; Arthur Karlin; John D Loike; Samuel C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

8.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Communication between receptors for different ligands on a single cell: ligation of fibronectin receptors induces a reversible alteration in the function of complement receptors on cultured human monocytes.

Authors:  S D Wright; M R Licht; L S Craigmyle; S C Silverstein
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

10.  Determination of the critical concentration of neutrophils required to block bacterial growth in tissues.

Authors:  Yongmei Li; Arthur Karlin; John D Loike; Samuel C Silverstein
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  2 in total

Review 1.  Immune-Mediated Repair: A Matter of Plasticity.

Authors:  Paôline Laurent; Valérie Jolivel; Pauline Manicki; Lynn Chiu; Cécile Contin-Bordes; Marie-Elise Truchetet; Thomas Pradeu
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

2.  Mathematical Modeling of Streptococcus pneumoniae Colonization, Invasive Infection and Treatment.

Authors:  Elisa Domínguez-Hüttinger; Neville J Boon; Thomas B Clarke; Reiko J Tanaka
Journal:  Front Physiol       Date:  2017-03-02       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.